Supplementary table S1 from Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma
Michaël H. Meel(Princess Máxima Center), Esther Hulleman(Amsterdam UMC Location VUmc), Olaf van Tellingen(The Netherlands Cancer Institute), Tonny Lagerweij(Amsterdam University Medical Centers), Rintaro Hashizume(Children's of Alabama), Dannis G. van Vuurden(Amsterdam UMC Location Vrije Universiteit Amsterdam), Mark C. de Gooijer(Manchester Academic Health Science Centre), Piotr Waranecki(Princess Máxima Center), Gertjan J.L. Kaspers(Emma Kinderziekenhuis), Jos W. R. Twisk(Amsterdam UMC Location VUmc), Eric H. Raabe(Johns Hopkins University), Laurine E. Wedekind(Amsterdam University Medical Centers), Dennis S. Metselaar(Princess Máxima Center), Kenn Zwaan(Amsterdam University Medical Centers), Timothy N. Phoenix(University of Cincinnati), Levi C.M. Buil(Cancer Genomics Centre), Marjolein Breur(Amsterdam University Medical Centers), Jan Köster(Amsterdam UMC Location University of Amsterdam), A. Sewing(Amsterdam University Medical Centers), Ángel M. Carcaboso(Hospital Sant Joan de Déu Barcelona), Marianna Bugiani(Amsterdam University Medical Centers)
Cited by 0
Related Papers
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711